Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1973 May;27(5):351–361. doi: 10.1038/bjc.1973.43

Cell-mediated Immunity and Antibodies to Herpesvirus hominis Type 1 in Oral Leukoplakia and Carcinoma

T Lehner, J M A Wilton, E J Shillitoe, L Ivanyi
PMCID: PMC2008806  PMID: 4351511

Abstract

Cell-mediated and humoral immune responses to Herpesvirus hominis type 1 (HVH1) and Candida albicans were studied in patients with leukoplakia, showing a histological spectrum of changes from epithelial keratosis to acanthosis and atypia, and in patients with carcinoma. The results were ranked according to increasing values of stimulation indices of lymphocyte transformation to HVH1, and the corresponding macrophage migration inhibition indices, and complement fixing antibody titres of each patient were correlated. This revealed that most patients with epithelial atypia were clustered to that end of the spectrum which had the highest stimulation and migration indices to HVH1; this relationship was not evident with C. albicans. In patients with keratosis and acanthosis there was a significant lack of correlation between lymphocyte transformation and migration inhibition to both HVH1 and C. albicans. In carcinoma the indices of lymphocyte transformation and migration inhibition to HVH1 and C. albicans were depressed. Furthermore, a significant negative correlation was found between lymphocyte transformation and migration inhibition to HVH1, unlike the positive correlation in control subjects. Complement fixing antibodies to HVH1, HVH2, cytomegalovirus and adenovirus, and fluorescent antibodies to C. albicans failed to show a significant change in titre in any one group of subjects tested. The results suggest a cell-mediated immune defect in leukoplakia, with a dissociation between lymphocyte transformation and macrophage migration inhibition to HVH1 and C. albicans in cases of keratosis or acanthosis. A specific increase in cell-mediated immunity to HVH1 in leukoplakia with epithelial atypia and the sequential changes argue in favour of a possible participation of HVH1 in carcinomatous transformation of some leukoplakias.

Full text

PDF
351

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aurelian L., Royston I., Davis H. J. Antibody to genital herpes simplex virus: association with cervical atypia and carcinoma in situ. J Natl Cancer Inst. 1970 Sep;45(3):455–464. [PubMed] [Google Scholar]
  2. BRADSTREET C. M., TAYLOR C. E. Technique of complementfixation test applicable to the diagnosis of virus diseases. Mon Bull Minist Health Public Health Lab Serv. 1962 May;21:96–104. [PubMed] [Google Scholar]
  3. Benezra D., Hochman A. In vitro activation of lymphocytes from patients with malignant diseases. I. Kinetics and differences in magnitude of response. Isr J Med Sci. 1971 Apr;7(4):553–560. [PubMed] [Google Scholar]
  4. Catalano L. W., Jr, Johnson L. D. Herpesvirus antibody and carcinoma in situ of the cervix. JAMA. 1971 Jul 26;217(4):447–450. [PubMed] [Google Scholar]
  5. Cawson R. A., Lehner T. Chronic hyperplastic candidiasis--candidal leukoplakia. Br J Dermatol. 1968 Jan;80(1):9–16. doi: 10.1111/j.1365-2133.1968.tb11899.x. [DOI] [PubMed] [Google Scholar]
  6. Dumonde D. C. 'Lymphokines': molecular mediators of cellular immune responses in animals and man. Proc R Soc Med. 1970 Sep;63(9):899–902. doi: 10.1177/003591577006300917. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Goldberg L. S., Bluestone R., Barnett E. V., Landau J. W. Studies on lymphocyte and monocyte function in chronic mucocutaneous candidiasis. Clin Exp Immunol. 1971 Jan;8(1):37–43. [PMC free article] [PubMed] [Google Scholar]
  8. Huebner R. J., Todaro G. J. Oncogenes of RNA tumor viruses as determinants of cancer. Proc Natl Acad Sci U S A. 1969 Nov;64(3):1087–1094. doi: 10.1073/pnas.64.3.1087. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Ivanyi L., Lehner T. Stimulation of lymphocyte transformation by bacterial antigens in patients with periodontal disease. Arch Oral Biol. 1970 Nov;15(11):1089–1096. doi: 10.1016/0003-9969(70)90121-4. [DOI] [PubMed] [Google Scholar]
  10. Ivanyi L., Wilton J. M., Lehner T. Cell-mediated immunity in periodontal disease; cytotoxicity, migration inhibition and lymphocyte transformation studies. Immunology. 1972 Jan;22(1):141–145. [PMC free article] [PubMed] [Google Scholar]
  11. Jones H. W., Jr, Katayama K. P., Stafl A., Davis H. J. Chromosomes of cervical atypia, carcinoma in situ, and epidermoid carcinoma of the cervix. Obstet Gynecol. 1967 Dec;30(6):790–805. [PubMed] [Google Scholar]
  12. Koss L. G. Concept of genesis and development of carcinoma of the cervix. Obstet Gynecol Surv. 1969 Jul;24(7 Pt 2):850–860. doi: 10.1097/00006254-196907001-00015. [DOI] [PubMed] [Google Scholar]
  13. Kramer I. R., Lucas R. B., el-Labban N., Lister L. A computer-aided study on the tissue changes in oral keratoses and lichen planus, and an analysis of case groupings by subjective and objective criteria. Br J Cancer. 1970 Sep;24(3):407–426. doi: 10.1038/bjc.1970.49. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Lehner T. Immunofluorescence study of Candida albicans in candidiasis, carriers and controls. J Pathol Bacteriol. 1966 Jan;91(1):97–104. doi: 10.1002/path.1700910114. [DOI] [PubMed] [Google Scholar]
  15. Lehner T. Immunopathology of oral leukoplakia. Br J Cancer. 1970 Sep;24(3):442–446. doi: 10.1038/bjc.1970.52. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Lehner T. Quantitative assessment of lymphocytes and plasma cells in leukoplakia, candidiasis, and lichen planus. J Dent Res. 1971 Nov-Dec;50(6):1661–1665. doi: 10.1177/00220345710500065201. [DOI] [PubMed] [Google Scholar]
  17. Lehner T. Serum fluorescent antibody and immunoglobulin estimations in candidosis. J Med Microbiol. 1970 Aug;3(3):475–481. doi: 10.1099/00222615-3-3-475. [DOI] [PubMed] [Google Scholar]
  18. Lehner T., Wilton J. M., Ivanyi L. Immunodeficiencies in chronic muco-cutaneous candidosis. Immunology. 1972 May;22(5):775–787. [PMC free article] [PubMed] [Google Scholar]
  19. Levene G. M., Wright D. J., Turk J. L. Cell-mediated immunity and lymphocyte transformation in syphilis. Proc R Soc Med. 1971 Apr;64(4):426–428. doi: 10.1177/003591577106400440. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Nahmias A. J., Naib Z. M., Josey W. E., Murphy F. A., Luce C. F. Sarcomas after inoculation of newborn hamsters with Herpes virus hominis type 2 strains. Proc Soc Exp Biol Med. 1970 Sep;134(4):1065–1069. doi: 10.3181/00379727-134-34945. [DOI] [PubMed] [Google Scholar]
  21. Naib Z. M., Nahmias A. J., Josey W. E., Kramer J. H. Genital herpetic infection. Association with cervical dysplasia and carcinoma. Cancer. 1969 Apr;23(4):940–945. doi: 10.1002/1097-0142(196904)23:4<940::aid-cncr2820230432>3.0.co;2-e. [DOI] [PubMed] [Google Scholar]
  22. RUBIN H. GENETIC CONTROL OF CELLULAR SUSCEPTIBILITY TO PSEUDOTYPES OF ROUS SARCOMA VIRUS. Virology. 1965 Jun;26:270–276. doi: 10.1016/0042-6822(65)90274-6. [DOI] [PubMed] [Google Scholar]
  23. Reed W. P., Olds J. W., Kisch A. L. Decreased skin-test reactivity associated with influenza. J Infect Dis. 1972 Apr;125(4):398–402. doi: 10.1093/infdis/125.4.398. [DOI] [PubMed] [Google Scholar]
  24. Southam C. M., Tanaka S., Arata T., Simkovic D., Miura M., Petropulos S. F. Enhancement of responses to chemical carcinogens by nononcogenic viruses and antimetabolites. Prog Exp Tumor Res. 1969;11:194–212. doi: 10.1159/000391394. [DOI] [PubMed] [Google Scholar]
  25. TANAKA S., SOUTHAM C. M. JOINT ACTION OF HERPES SIMPLEX VIRUS AND 3-METHYLCHOLANTHRENE IN PRODUCTION OF PAPILLOMAS IN MICE. J Natl Cancer Inst. 1965 Apr;34:441–451. [PubMed] [Google Scholar]
  26. Thor D. E., Jureziz R. E., Veach S. R., Miller E., Dray S. Cell migration inhibition factor released by antigen from human peripheral lymphocytes. Nature. 1968 Aug 17;219(5155):755–757. doi: 10.1038/219755a0. [DOI] [PubMed] [Google Scholar]
  27. Valdimarsson H., Holt L., Riches H. R., Hobbs J. R. Lymphocyte abnormality in chronic mucocutaneous candidiasis. Lancet. 1970 Jun 13;1(7659):1259–1261. doi: 10.1016/s0140-6736(70)91742-3. [DOI] [PubMed] [Google Scholar]
  28. WYBURN-MASON R. Malignant change following herpes simplex. Br Med J. 1957 Sep 14;2(5045):615–616. doi: 10.1136/bmj.2.5045.615. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Wilton J. M., Ivanyi L., Lehner T. Cell-mediated immunity in Herpesvirus hominis infections. Br Med J. 1972 Mar 18;1(5802):723–726. doi: 10.1136/bmj.1.5802.723. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES